| Drug Name |
Interferon beta-1a |
| Drug ID |
BADD_D01169 |
| Description |
Human interferon beta (166 residues), glycosylated, MW=22.5kD. It is produced by mammalian cells (Chinese Hamster Ovary cells) into which the human interferon beta gene has been introduced. The amino acid sequence is identical to that of natural human interferon beta. |
| Indications and Usage |
For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum |
| Marketing Status |
approved; investigational |
| ATC Code |
L03AB07 |
| DrugBank ID |
DB00060
|
| KEGG ID |
D04554
|
| MeSH ID |
D000068556
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D0V4JQ
|
| NDC Product Code |
44087-0044; 44087-0022; 44087-3344; 59627-003; 44087-3322; 59627-222; 59627-125; 44087-8822; 44087-0188; 59627-002; 59627-333 |
| UNII |
XRO4566Q4R
|
| Synonyms |
Interferon beta-1a | beta-1a, Interferon | Interferon beta 1a | beta 1a, Interferon | Avonex Pen | Rebif | Avonex |
